management-header-3.jpg

Meet the minds behind our innovation.

Marinus Pharmaceuticals’ management team is committed to developing ganaxolone for treatment of drug-resistant seizures and neuropsychiatric disorders in both the hospital and home settings.

ronaldo gutierrez esteinou

Dr. Gutíerrez-Esteinou has more than 20 years of experience in the clinical development of neuropsychiatric and CNS therapies.

Rolando Gutíerrez-Esteinou, M.D., Vice President of Clinical Development and Pharmacovigilance

Dr. Gutíerrez-Esteinou has more than 20 years of experience in the clinical development of neuropsychiatric and CNS therapies. As Vice President of Clinical Development and Pharmacovigilance at Marinus, he will primarily be responsible for the medical leadership of the postpartum depression programs and drug safety. Dr. Gutíerrez-Esteinou was previously Executive Director and Global Clinical Leader, Psychiatry, at Takeda Pharmaceuticals, and Vice President and Global Therapeutic Area Head at Covance Clinical Development Services. He has also held positions at Prostrakan, Inc.; Bristol-Myers Squibb; Novartis Pharmaceuticals; and the Janssen Research Foundation.

Dr. Gutíerrez-Esteinou holds an M.D. from the National Autonomous University of Mexico Medical School, Mexico City, and was a resident and research fellow at Harvard Medical School.

icon patient resources

Explore Patient Resources

Find helpful information and patient networks, as well as clinical trial opportunities.

View Patient Resources

icon join marinus team

Join the Marinus Team

Learn how you can become part of our mission to advance mindful innovation.

Visit Careers Center